Oxipital AI Raises Series A Funding to Expand V-CORTX Vision Platform

Oxipital AI has closed a Series A funding round co-led by SAS Private Equities and Scale Venture Partners, according to a press release. The funding will support the expansion and deployment of Oxipital AI's V-CORTX platform, which provides AI vision technology for manufacturing operations.

The company reported strong commercial growth, with increasing adoption of the V-CORTX platform by global food manufacturers. It expects annual revenue growth of 400 percent in 2026, supported by new production contracts that include 120 AI vision systems for foreign object detection across multiple facilities.

V-CORTX applies synthetic model training to support quality control, yield optimization, and vision-guided robotics in variable manufacturing conditions. The platform also provides analytics for production traceability and operational decision making.

Scale Venture Partners noted that Oxipital AI’s approach addresses long-standing reliability issues in machine vision, and its performance at scale among food manufacturers demonstrates significant demand for adaptable automation solutions.